Oktay Ayse Nur, Ilbasmis-Tamer Sibel, Han Sevtap, Uludag Orhan, Celebi Nevin
Department of Pharmaceutical Technology, Gazi University-Faculty of Pharmacy, Ankara, Turkey.
Department of Pharmacology, Gazi University-Faculty of Pharmacy, Ankara, Turkey.
Eur J Pharm Sci. 2020 Dec 1;155:105548. doi: 10.1016/j.ejps.2020.105548. Epub 2020 Sep 13.
Flurbiprofen (FB) is an analgesic and anti-inflammatory drug, but its low water solubility (BCS Class II) limits its dermal bioavailability. The aim of this study is to develop a FB nanosuspension (NS) based gel and to evaluate its analgesic and anti-inflammatory activities in rats. FB-NS was produced by the wet milling method with Plantacare 2000, as stabilizer. The FB-NS was then incorporated in different carrier gels such as hydroxypropyl methyl cellulose (HPMC), polycarbophil, oleogel, and chitosan. To select the optimum gel type, visual examinations, pH and rheological property measurements, texture profile analysis, in vitro release and ex vivo permeation studies were performed. Following these tests, the analgesic and anti-inflammatory activities of the optimum NS based gel were evaluated using the tail flick and carrageenan-induced paw edema methods consecutively. The NS was successfully prepared with the wet milling method, and the PS, PDI and ZP values were found to be 237.7 ± 6.8 nm, 0.133±0.030, and -30.4 ± 0.7 mV; respectively. Among the NS-based gels, HPMC gel showed more suitable rheological and mechanical properties, also the percentage of permeated FB and the flux value observed for HPMC gel were higher for HPMC than for the other gels. Thus, HPMC gel was selected as a carrier gel for in vivo pharmacodynamics studies. The anti-inflammatory activity of FB-NS HPMC gel was higher than that of the physical mixture gel and that of the coarse suspension gel. Results of our analgesic activity studies showed that, in the 180th min of FB nanosuspension treatment, the latency time was significantly prolonged compared to that of the control group (p<0.05). As a conclusion, while nanosuspensions increased the in vivo pharmacodynamics effect of FB by means of nanosized particles and a large surface area, the HPMC gel as a carrier prolonged the contact time of NSs with skin and eased the dermal application.
氟比洛芬(FB)是一种镇痛和抗炎药物,但其低水溶性(BCS II类)限制了其皮肤生物利用度。本研究的目的是开发一种基于氟比洛芬纳米混悬液(NS)的凝胶,并评估其在大鼠中的镇痛和抗炎活性。采用湿磨法,以普兰卡瑞2000为稳定剂制备氟比洛芬纳米混悬液。然后将氟比洛芬纳米混悬液加入不同的载体凝胶中,如羟丙基甲基纤维素(HPMC)、聚卡波非、油凝胶和壳聚糖。为了选择最佳凝胶类型,进行了外观检查、pH和流变学性质测量、质地剖面分析、体外释放和离体渗透研究。经过这些测试,使用甩尾法和角叉菜胶诱导的爪肿胀法依次评估了最佳纳米混悬液基凝胶的镇痛和抗炎活性。通过湿磨法成功制备了纳米混悬液,其粒径、多分散指数和ζ电位值分别为237.7±6.8nm、0.133±0.030和-30.4±0.7mV。在纳米混悬液基凝胶中,HPMC凝胶表现出更合适的流变学和力学性质,而且HPMC凝胶的氟比洛芬渗透百分比和通量值高于其他凝胶。因此,选择HPMC凝胶作为体内药效学研究的载体凝胶。氟比洛芬纳米混悬液HPMC凝胶的抗炎活性高于物理混合凝胶和粗混悬液凝胶。我们的镇痛活性研究结果表明,在氟比洛芬纳米混悬液治疗的第180分钟,与对照组相比,潜伏期显著延长(p<0.05)。总之,纳米混悬液通过纳米级颗粒和大表面积增加了氟比洛芬的体内药效学作用,而HPMC凝胶作为载体延长了纳米混悬液与皮肤的接触时间,便于经皮给药。